Background: A standard of care for the treatment of small renal masses is partial nephrectomy. The open and laparoscopic approaches have been well described in the literature. Robotic assistance may ...

In the treatment of small renal masses, robotic partial nephrectomy (RPN) has a superior morbidity profile compared with laparoscopic partial nephrectomy (LPN), according to an updated meta-analysis ...

The probability of surgical success with telesurgery for radical prostatectomy and partial nephrectomy for small renal masses was non-inferior to local robotic surgery in a small randomized trial. The ...

Please provide your email address to receive an email when new articles are posted on . Lower rates of adverse outcomes were linked to higher technical skill Surgeons with higher scores had lower ...

Routine use of expensive hemostatic agents during RALPN does not seem to be justified. The use of hemostatic agents (HAs) during standard robotic-assisted laparoscopic partial nephrectomy (RALPN) does ...

For completely endophytic kidney tumors, which grow inward, both open partial nephrectomy (OPN) and robotic partial nephrectomy (RPN) led to excellent patient outcomes in a recent study. When ...

University of Iowa Health announced in early February 2026 that it had successfully completed its first robotic living donor nephrectomy ...

An international study examined outcomes between a single-port (SP) versus a multi-port (MP) approach to RAPN, with a focus on elderly patients. Despite similar demographics among patients ≤64 years ...

Banner University Medicine Tucson has reached a milestone by completing its first robotic-assisted living donor nephrectomy.

Add Yahoo as a preferred source to see more of our stories on Google. New research suggests that a surgeon no longer needs to be in the same room as the patient, and that operating on a patient ...

Patna: Doctors at the Indira Gandhi Institute of Medical Sciences (IGIMS) will perform three kidney-related robotic surgeries on Friday, including two for kidney cancer, as its ongoing clinical trial ...